Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.44
-0.0650-1.86%
Volume:588.94K
Turnover:2.03M
Market Cap:377.08M
PE:-20.21
High:3.56
Open:3.50
Low:3.41
Close:3.50
52wk High:5.45
52wk Low:2.53
Shares:109.77M
Float Shares:85.39M
Volume Ratio:0.50
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:1.02
PE(LYR):-1.71

Loading ...

May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Apr 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities